Phibro Animal Health (PAHC) Misses Q3 EPS by 5c

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.29, $0.05 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $245.7 million versus the consensus estimate of $247.37 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'